In our study, Two patients with TBC1D23 de novo frameshift mutations exhibited controlled seizure, brainstem findings (vertigo, dysphagia, dizziness), gait disorder (ataxia and spastic), cardiovascular (atrial septal defect), hypothyroidism, and scoliosis which were not typically reported in the literature. Here, TBC1D23 is linked to Vertigo.